3|0|Public
50|$|<b>Flopristin</b> {{is one of}} the {{components}} of the experimental drug NXL103.|$|E
50|$|<b>Flopristin</b> is a semi-synthetic {{antibiotic}} of the streptogramin A class. It is a fluorinated {{derivative of}} pristinamycin IIB.|$|E
5000|$|NXL103 (formerly XRP 2868) is an {{experimental}} drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) {{as well as}} the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. [...] It is a combination of linopristin and <b>flopristin.</b>|$|E

